Generex Biotechnology Announces That FDA has Accepted the Pre-IND Briefing Package for the Company’s Ii-Key-SARS-CoV-2 Vaccine and Will Provide a Written Response by August 24, 2020

MIRAMAR, Fla., July 27, 2020 (GLOBE NEWSWIRE) — Generex Biotechnology Corporation (www.generex.com) (OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the FDA has

Read more

Pressure BioSciences, Inc. and ISS, Inc. Announce Two-Year Worldwide Co-Marketing and Distribution Agreement

ISS High Pressure Optical Cell Integrated with PBI Automated High Pressure Instrument: Combination Results in Unique Analytical System with Potential to Significantly

Read more

Pressure BioSciences, Inc., a Leader in the Sale of Pressure-Based Solutions for the Worldwide Life Sciences Market, to Host Webinar Update for Investors

Company to Discuss Expected Impact on 2018 Revenue from Recent Product Enhancements, New Field Salesforce, Technology Asset Acquisition, and Newly

Read more